Loading
collectionsCollection
LUNGevity Foundation (and GO2 for Lung Cancer)
LUNGevity is the largest US lung cancer charity, focused on making sure every patient gets comprehensive biomarker testing and access to targeted therapy and trials, with a screening-advocacy partner in GO2.
Overview
LUNGevity (founded 2001) runs 'No One Missed' biomarker testing campaigns, patient education for each driver (EGFR, ALK, ROS1, KRAS G12C, MET, RET, HER2, NTRK, BRAF), the Lung Cancer Registry patient-reported research platform, HOPE Summits for survivors, and translational research awards. GO2 for Lung Cancer (Bonnie J. Addario Lung Cancer Foundation + Lung Cancer Alliance) runs the Centers of Excellence network for screening and care. Driver-specific patient groups (ALK Positive, EGFR Resisters, ROS1ders, KRAS Kickers, MET Crusaders) have become influential research partners.
Holds
Biomarker testing education, the Lung Cancer HELPLine, patient-facing trial finder, survivorship programmes, research awards, and the Lung Cancer Registry; GO2 runs the Centers of Excellence and screening advocacy.
Licence
Copyright LUNGevity
Maintainer
LUNGevity Foundation
Similar pages
- CollectionColorectal Cancer Alliance
Shares KRAS and the tag patient-org.
- Key paperNILE: clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer
- PersonKaren Kelly
Shares International Association for the Study of Lung Cancer, Small-cell lung cancer, Non-small-cell lung cancer.
- CompanyLucence
Shares ALK, EGFR, KRAS, Comprehensive genomic profiling.
- CompanyInivata
Shares ALK, EGFR, KRAS, Comprehensive genomic profiling.
- Key paperClinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer
Shares ROS1, ALK, EGFR, Comprehensive genomic profiling.
- CollectionPancreatic Cancer Action Network (PanCAN)
Shares Comprehensive genomic profiling and the tag patient-org.
- InstitutionShanghai Pulmonary Hospital
Shares ALK, EGFR, Small-cell lung cancer, Non-small-cell lung cancer.